NCT04829227View on ClinicalTrials.gov

Safety and Efficacy of Sofwave Treatment to Lift Lax Skin

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Skin Laxity
Interventions
DEVICE

Sofwave

The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.

Trial Locations (4)

23462

McDaniel Institute of Aging Research, Virginia Beach

37203

The Practice of Brian S. Biesman, MD, Nashville

37215

Tennessee Clinical Research Center, Nashville

07601

SLSS, a Division of Schweiger Dermatology Group Research Office, Hackensack

All Listed Sponsors
lead

Sofwave Medical LTD

INDUSTRY

NCT04829227 - Safety and Efficacy of Sofwave Treatment to Lift Lax Skin | Biotech Hunter | Biotech Hunter